La vendita allo scoperto per ALPS ETF Trust ALPS dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di ALPS ETF Trust ALPS. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

ALPS ETF Trust ALPS (ARCA:SMTH), Report sulle vendite allo scoperto

ALPS ETF Trust ALPS

The Fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in bonds. Bonds include, but are not limited to, government notes and bonds, corporate bonds, convertible bonds, commercial and residential mortgage-backed securities, and zero-coupon bonds. The Fund will target a weighted average effective duration +/- 40% of the current effective duration of the Bloomberg U.S. Aggregate Bond Index, which was 8.5412 years, as of August 31, 2023. The Fund does not intend to invest in contingent convertible bonds.

ALPS Smith Core Plus Bond ETF

Across the recent three months, 11 analysts have shared their insights on Diamondback Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>), expressing a variety of opinions spanning from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Diamondback Energy, revealing an average target of $219.09, a high estimate of $256.00, and a low estimate of $190.00. Highlighting a 0.66% decrease, the current average has fallen from the previous average price target of $220.55. 
<img src="https://www.benzinga.com/files/images/story/2025/1739476859_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Diamondback Energy. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$216.00</td>
<td>$212.00</td>
</tr>
<tr>
<td>John Freeman</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$256.00</td>
<td>$237.00</td>
</tr>
<tr>
<td>Scott Hanold</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$210.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$195.00</td>
<td>$191.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$236.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Doug Leggate</td>
<td>Wolfe Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$190.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$232.00</td>
<td>$252.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$219.00</td>
<td>$218.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$207.00</td>
<td>$219.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$212.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>John Freeman</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$237.00</td>
<td>$232.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Diamondback Energy. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Diamondback Energy compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Diamondback Energy's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into Diamondback Energy's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/FANG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Diamondback Energy analyst ratings.</a>
<h2>Unveiling the Story Behind Diamondback Energy</h2>
Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2023, the company reported net proven reserves of 2.2 billion barrels of oil equivalent. Net production averaged about 448,000 barrels per day in 2023, at a ratio of 59% oil, 21% natural gas liquids, and 20% natural gas.
<h3>Unraveling the Financial Story of Diamondback Energy</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Positive Revenue Trend: Examining Diamondback Energy's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 13.03% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Energy sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 24.91%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.4%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Diamondback Energy's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 1.3%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 0.35, Diamondback Energy adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

FANG

11 Analysts Have This To Say About Diamondback Energy

In the latest quarter, 4 analysts provided ratings for QuidelOrtho (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QDEL#NASDAQ">QDEL</a>), showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $49.75, a high estimate of $61.00, and a low estimate of $43.00. A 1.15% drop is evident in the current average compared to the previous average price target of $50.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1739476846_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive QuidelOrtho. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Conor McNamara</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$61.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>John Sourbeer</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$45.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$50.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Tycho Peterson</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Hold</td>
<td>$43.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to QuidelOrtho. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of QuidelOrtho compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for QuidelOrtho's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into QuidelOrtho's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/QDEL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on QuidelOrtho analyst ratings.</a>
<h2>Get to Know QuidelOrtho Better</h2>
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
<h3>Unraveling the Financial Story of QuidelOrtho</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: QuidelOrtho's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -2.27%. This indicates a decrease in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: QuidelOrtho's net margin excels beyond industry benchmarks, reaching -2.74%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): QuidelOrtho's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.63% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): QuidelOrtho's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.29%, the company showcases efficient use of assets and strong financial health.
Debt Management: QuidelOrtho's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.86.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

QDEL

Where QuidelOrtho Stands With Analysts

5 analysts have expressed a variety of opinions on Everus Construction Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECG#NYSE">ECG</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Everus Construction Group, presenting an average target of $76.0, a high estimate of $85.00, and a low estimate of $67.00. Holding firm without variation, the current average remains at the previous average price target. 
<img src="https://www.benzinga.com/files/images/story/2025/1739476838_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Everus Construction Group among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian Brophy</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$67.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Brian Brophy</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$85.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Ian Zaffino</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$80.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Brian Brophy</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$78.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Ian Zaffino</td>
<td>Oppenheimer</td>
<td>Announces</td>
<td>Outperform</td>
<td>$70.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Everus Construction Group. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Everus Construction Group compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Everus Construction Group's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Everus Construction Group's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ECG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Everus Construction Group analyst ratings.</a>
<h2>About Everus Construction Group</h2>
Everus Construction Group Inc is a construction solutions provider, offering specialty contracting services to a diverse set of end markets across the U.S. It operates across two segments, Electrical &amp; Mechanical (E&amp;M) and Transmission &amp; Distribution (T&amp;D), and delivers services through its subsidiaries. It generates the majority of revenue from the Electrical &amp; Mechanical segment which offers a wide variety of specialty contracting services, including construction and maintenance of electrical and communication wiring, fire suppression systems, and mechanical piping and services, to customers in both the public and private sectors. Its T&amp;D segment serves electric and natural gas utility customers, as well as customers in the transportation end market, in the West and Midwest regions.
<h3>Everus Construction Group's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Everus Construction Group's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 6.07% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Everus Construction Group's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.49% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Everus Construction Group's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.79% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Everus Construction Group's ROA stands out, surpassing industry averages. With an impressive ROA of 3.27%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Everus Construction Group's debt-to-equity ratio is below the industry average. With a ratio of 0.63, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Everus Construction Group: 5 Analysts Share Their Views

Financial giants have made a conspicuous bearish move on United States Steel. Our analysis of options history for United States Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) revealed 20 unusual trades.
Delving into the details, we found 45% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $357,165, and 14 were calls, valued at $464,689.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $35.0 and $45.0 for United States Steel, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in United States Steel's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to United States Steel's substantial trades, within a strike price spectrum from $35.0 to $45.0 over the preceding 30 days.
<h3>United States Steel 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739476833_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>X</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$10.0</td>
<td>$8.35</td>
<td>$8.45</td>
<td>$42.00</td>
<td>$168.9K</td>
<td>759</td>
<td align="right">200</td>
</tr>
<tr>
<td>X</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$7.65</td>
<td>$6.2</td>
<td>$7.65</td>
<td>$45.00</td>
<td>$51.2K</td>
<td>3.5K</td>
<td align="right">77</td>
</tr>
<tr>
<td>X</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$4.65</td>
<td>$4.3</td>
<td>$4.45</td>
<td>$36.00</td>
<td>$44.5K</td>
<td>364</td>
<td align="right">21</td>
</tr>
<tr>
<td>X</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$5.9</td>
<td>$4.4</td>
<td>$4.4</td>
<td>$39.00</td>
<td>$43.5K</td>
<td>831</td>
<td align="right">104</td>
</tr>
<tr>
<td>X</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$4.2</td>
<td>$4.15</td>
<td>$4.18</td>
<td>$38.00</td>
<td>$41.6K</td>
<td>1.4K</td>
<td align="right">116</td>
</tr>
</tbody>
</table>

<h3>About United States Steel</h3>
United States Steel Corp operates in the United States but also has a steelmaking capacity in Slovakia. The company's operating segments include North American Flat-Rolled (Flat-Rolled), Mini Mill, U. S. Steel Europe (USSE), and Tubular Products (Tubular). The Flat-Rolled segment includes U. S. Steel's integrated steel plants and equity investees in North America involved in the production of slabs, strip mill plates, sheets, and tin mill products, as well as all iron ore and coke production facilities in the United States. It serves North American customers in the service center, conversion, transportation, construction, container, and appliance, and electrical markets.
<h3>Current Position of United States Steel</h3>
<ul>
<li>With a volume of 3,644,149, the price of X is down -0.82% at $38.23. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 77 days.</li>
</ul>
<h3>What The Experts Say On United States Steel</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $39.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Morgan Stanley lowers its rating to Equal-Weight with a new price target of $39. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on United States Steel with a target price of $40. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for United States Steel with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Markets

What the Options Market Tells Us About United States Steel

Deep-pocketed investors have adopted a bullish approach towards Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CELH usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 18 extraordinary options activities for Celsius Holdings. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 55% leaning bullish and 44% bearish. Among these notable options, 3 are puts, totaling $263,323, and 15 are calls, amounting to $533,258.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $15.0 and $50.0 for Celsius Holdings, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Celsius Holdings's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Celsius Holdings's whale trades within a strike price range from $15.0 to $50.0 in the last 30 days. 
<h3>Celsius Holdings Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739476827_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CELH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$7.85</td>
<td>$7.75</td>
<td>$7.85</td>
<td>$27.50</td>
<td>$196.2K</td>
<td>579</td>
<td>250</td>
</tr>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$1.6</td>
<td>$1.59</td>
<td>$1.59</td>
<td>$30.00</td>
<td>$77.1K</td>
<td>4.7K</td>
<td>1.2K</td>
</tr>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$0.79</td>
<td>$0.57</td>
<td>$0.78</td>
<td>$24.00</td>
<td>$39.0K</td>
<td>1.9K</td>
<td>1.0K</td>
</tr>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$9.85</td>
<td>$9.7</td>
<td>$9.7</td>
<td>$20.00</td>
<td>$38.8K</td>
<td>681</td>
<td>56</td>
</tr>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$0.77</td>
<td>$0.74</td>
<td>$0.77</td>
<td>$24.00</td>
<td>$38.5K</td>
<td>1.9K</td>
<td>510</td>
</tr>
</tbody>
</table>

<h3>About Celsius Holdings</h3>
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.
Following our analysis of the options activities associated with Celsius Holdings, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Celsius Holdings</h3>
<ul>
<li>Currently trading with a volume of 5,108,459, the CELH's price is up by 1.03%, now at $21.5. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 14 days.</li>
</ul>
<h3>What The Experts Say On Celsius Holdings</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $36.75.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Stifel has decided to maintain their Buy rating on Celsius Holdings, which currently sits at a price target of $37. 
&#x2A; An analyst from Needham downgraded its action to Buy with a price target of $38. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Celsius Holdings with a target price of $33. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Celsius Holdings with a target price of $39. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Celsius Holdings with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

CELH

Celsius Holdings's Options Frenzy: What You Need to Know

In the preceding three months, 4 analysts have released ratings for Coastal Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCB#NASDAQ">CCB</a>), presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $97.0, with a high estimate of $100.00 and a low estimate of $92.00. This upward trend is evident, with the current average reflecting a 9.3% increase from the previous average price target of $88.75.
<img src="https://www.benzinga.com/files/images/story/2025/1739476827_0_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The perception of Coastal Finl by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Terrell</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>David Feaster</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$100.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Timothy Switzer</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$96.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Timothy Switzer</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$92.00</td>
<td>$75.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Coastal Finl. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Coastal Finl compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Coastal Finl's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Coastal Finl's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CCB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Coastal Finl analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Coastal Finl</h2>
Coastal Financial Corp is a financial service provider. The company provides banking products and services to consumers and small to medium-sized businesses. Its business is conducted through three reportable segments: The community bank, CCBX, and treasury &amp; administration. The primary focus of the community bank is on providing a wide range of banking products and services to consumers and small to medium-sized businesses in the broader Puget Sound region in the state of Washington and through the Internet and mobile banking applications.
<h3>Coastal Finl's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Decline in Revenue: Over the 3 months period, Coastal Finl faced challenges, resulting in a decline of approximately -3.56% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 11.79%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Coastal Finl's ROE excels beyond industry benchmarks, reaching 3.47%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.33%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.12.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

4 Analysts Assess Coastal Finl: What You Need To Know

Investors with a lot of money to spend have taken a bullish stance on Merck &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MRK, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 18 uncommon options trades for Merck &amp; Co.
This isn't normal.
The overall sentiment of these big-money traders is split between 72% bullish and 22%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $683,798, and 9 are calls, for a total amount of $354,290.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $75.0 to $135.0 for Merck &amp; Co over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Merck &amp; Co options trades today is 2441.71 with a total volume of 4,415.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Merck &amp; Co's big money trades within a strike price range of $75.0 to $135.0 over the last 30 days.
<h3>Merck &amp; Co Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739476821_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRK</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$8.4</td>
<td>$8.3</td>
<td>$8.4</td>
<td>$90.00</td>
<td>$251.1K</td>
<td>2.8K</td>
<td align="right">2</td>
</tr>
<tr>
<td>MRK</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$9.55</td>
<td>$9.35</td>
<td>$9.35</td>
<td>$90.00</td>
<td>$93.5K</td>
<td>3.5K</td>
<td align="right">151</td>
</tr>
<tr>
<td>MRK</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$6.95</td>
<td>$6.4</td>
<td>$6.4</td>
<td>$75.00</td>
<td>$81.9K</td>
<td>498</td>
<td align="right">130</td>
</tr>
<tr>
<td>MRK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$1.82</td>
<td>$1.81</td>
<td>$1.81</td>
<td>$90.00</td>
<td>$69.1K</td>
<td>13.9K</td>
<td align="right">246</td>
</tr>
<tr>
<td>MRK</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$1.76</td>
<td>$1.71</td>
<td>$1.71</td>
<td>$75.00</td>
<td>$59.8K</td>
<td>1.2K</td>
<td align="right">352</td>
</tr>
</tbody>
</table>

<h3>About Merck &amp; Co</h3>
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
In light of the recent options history for Merck &amp; Co, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Merck &amp; Co</h3>
<ul>
<li>With a trading volume of 10,802,710, the price of MRK is down by -0.75%, reaching $85.03.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 70 days from now.</li>
</ul>
<h3>What The Experts Say On Merck &amp; Co</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $108.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Guggenheim has decided to maintain their Buy rating on Merck &amp; Co, which currently sits at a price target of $115. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Merck &amp; Co, which currently sits at a price target of $106. 
&#x2A; An analyst from Citigroup persists with their Buy rating on Merck &amp; Co, maintaining a target price of $115. 
&#x2A; An analyst from BMO Capital persists with their Market Perform rating on Merck &amp; Co, maintaining a target price of $96. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for Merck &amp; Co, targeting a price of $112. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Merck &amp; Co, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Decoding Merck & Co's Options Activity: What's the Big Picture?

8 analysts have expressed a variety of opinions on Martin Marietta Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLM#NYSE">MLM</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $619.0, with a high estimate of $650.00 and a low estimate of $600.00. Experiencing a 3.53% decline, the current average is now lower than the previous average price target of $641.62. 
<img src="https://www.benzinga.com/files/images/story/2025/1739476820_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Martin Marietta Materials among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Patrick Tyler Brown</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$600.00</td>
<td>$630.00</td>
</tr>
<tr>
<td>Trey Grooms</td>
<td>Stephens &amp; Co.</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$650.00</td>
<td>$675.00</td>
</tr>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$610.00</td>
<td>$670.00</td>
</tr>
<tr>
<td>Adam Seiden</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$600.00</td>
<td>$645.00</td>
</tr>
<tr>
<td>Patrick Tyler Brown</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$630.00</td>
<td>$640.00</td>
</tr>
<tr>
<td>Anthony Pettinari</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$600.00</td>
<td>$701.00</td>
</tr>
<tr>
<td>Angel Castillo</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$622.00</td>
<td>$657.00</td>
</tr>
<tr>
<td>Adrian Heurta</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$640.00</td>
<td>$515.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Martin Marietta Materials. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Martin Marietta Materials compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Martin Marietta Materials's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Capture valuable insights into Martin Marietta Materials's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MLM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Martin Marietta Materials analyst ratings.</a>
<h2>Unveiling the Story Behind Martin Marietta Materials</h2>
Martin Marietta Materials is one of the United States' largest producer of construction aggregates (crushed stone, sand, and gravel). In 2023, Martin Marietta sold 199 million tons of aggregates. Martin Marietta's most important markets include Texas, Colorado, North Carolina, Georgia, and Florida, accounting for most of its sales. The company also produces cement in Texas and uses its aggregates in its asphalt and ready-mixed concrete businesses. Martin's magnesia specialties business produces magnesia-based chemical products and dolomitic lime.
<h3>Martin Marietta Materials's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Challenges: Martin Marietta Materials's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -5.27%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 19.22%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Martin Marietta Materials's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 4.03%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Martin Marietta Materials's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 2.21%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Martin Marietta Materials's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.48.
<h2>The Significance of Analyst Ratings Explained</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

8 Analysts Assess Martin Marietta Materials: What You Need To Know

Throughout the last three months, 9 analysts have evaluated Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>), offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Manhattan Associates, presenting an average target of $283.0, a high estimate of $326.00, and a low estimate of $244.00. This current average has decreased by 8.04% from the previous average price target of $307.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1739476813_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Manhattan Associates among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Schappel</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$275.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$270.00</td>
<td>$315.00</td>
</tr>
<tr>
<td>Brian Peterson</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$270.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Quinton Gabrielli</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$268.00</td>
<td>$326.00</td>
</tr>
<tr>
<td>Terry Tillman</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$285.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>George Kurosawa</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$244.00</td>
<td>$303.00</td>
</tr>
<tr>
<td>George Kurosawa</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$303.00</td>
<td>$306.00</td>
</tr>
<tr>
<td>George Kurosawa</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$306.00</td>
<td>$287.00</td>
</tr>
<tr>
<td>Quinton Gabrielli</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Overweight</td>
<td>$326.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Manhattan Associates. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Manhattan Associates compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Manhattan Associates's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
For valuable insights into Manhattan Associates's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MANH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Manhattan Associates analyst ratings.</a>
<h2>Unveiling the Story Behind Manhattan Associates</h2>
Manhattan Associates provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers around the world.
<h3>Manhattan Associates: Delving into Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Challenges: Manhattan Associates's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -4.08%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Manhattan Associates's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 18.77% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Manhattan Associates's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 16.64%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 6.6%, the company showcases effective utilization of assets.
Debt Management: Manhattan Associates's debt-to-equity ratio is below the industry average. With a ratio of 0.16, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Significance of Analyst Ratings Explained</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MANH

Analyst Expectations For Manhattan Associates's Future

Egg prices have soared in recent months and stores are taking action to limit purchases in the wake of rising bird flu cases that could see costs <a href="https://www.benzinga.com/general/health-care/25/01/43372753/eggs-prices-soar-as-bird-flu-spreads-why-experts-expect-another-45-increase-in-2025">continue to rise.</a>
What Happened: The cost of eggs was up 15.2% in the<a href="https://www.benzinga.com/25/02/43663963/record-high-egg-prices-drive-inflation-higher-in-january"> month of January,</a> the largest increase since June 2015, which made the food item one of the biggest factors of rising inflation in the latest CPI report.
A dozen eggs costs $4.95 nationwide on average and the U.S. Department of Agriculture predicts the cost could rise another 45% in 2025 as bird flu cases rise.
Retailers including Costco (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>), Trader Joe's and Sprouts Farmers Market (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) are limiting the number of eggs that consumers can buy in the wake of the surging prices and limited supplies, as <a href="https://abcnews.go.com/US/grocery-stores-limit-egg-purchases-thefts-increase-bird-flu/story?id=118732180">reported </a>by ABC News.
Bodegas in New York are taking matters into their own hands to offer a solution to consumers who need to buy a few eggs at a time and can't afford the $10+ cost per dozen eggs in the state.
Pamela's Green Deli in the Bronx is selling "loosie"-style eggs, similar to selling single cigarettes, to consumers, as <a href="https://nypost.com/2025/02/12/us-news/nyc-bodegas-selling-loosie-eggs-as-prices-of-cartons-skyrocket/">reported </a>by the New York Post.
"These people don't have enough money to buy a dozen eggs, so I have to sell them separately," Pamel's Green Deli owner Fernando Rodriguez told the Post. "When I saw how high the price of eggs has become, we decided to break it down into small bags."
Rodriguez said the store previously sold a dozen eggs for $2.49 before the recent spikes related to bird flu. A plastic bag of three eggs now sells for $2.99 at the store.
The store, which serves a large number of low-income consumers, is seeing demand for the loosies over buying a dozen eggs at a time. Rodriguez said around one-third of the store's customers are buying the three packs rather than the dozen eggs.
Rodriguez, who is from the Dominican Republic, said that his home country used to sell single eggs. "I know how difficult it is for families to afford eggs and milk."
Other bodegas are catching on to the practice and using the same method. According to the report, selling cigarettes individually is illegal and selling eggs out of the dozen could also be a potential illegal practice.
Read Also: <a href="https://www.benzinga.com/25/02/43667841/inflation-is-hot-and-getting-hotter">Inflation Runs Hot In January: &#8216;Houston We Have A Problem,&#8217; Experts Warn</a>
Why It's Important: The USDA reports that 150 million poultry birds have been killed since 2022 as bird flu continues to spread across the country. The spike in bird flu is leading to less egg-producing birds and causing shortages.
The number of poultry birds killed has risen in recent months with seven million in November, 18 million in December and 23 million in January.
On Wednesday, the state of Ohio reported its first human case of bird flu with a farm worker in Mercer County being infected. There have been 68 human cases of bird flu in 11 states since 2024, as <a href="https://www.usatoday.com/story/news/health/2025/02/13/bird-flu-ohio-first-human-case/78510403007/">reported </a>by USA Today.  
People who work with poultry, dairy cows and waterfowl are most at risk of becoming infected with bird flu, like the Ohio worker.
Cal-Maine Foods Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>), the nation's largest egg producer is likely to come under pressure as egg prices rise. The company's recent second-quarter financial results saw revenue of $954.7 million significantly beat a Street consensus estimate of $751.5 million.
The company has beaten analyst estimates for earnings per share and revenue in four straight quarters according to data <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021325&amp;t=be2bearmibe3na1">from Benzinga Pro</a>. The better-than-expected results come as the cost of eggs have soared for consumers.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/25/02/43667632/inflation-rises-in-january-housing-costs-up-adding-to-consumers-2025-concerns">Inflation Rises In January, Housing Costs Up, Adding To Consumers&#8217; 2025 Concerns</a></li>
</ul>

News

CALM

COST

Egg Prices Hit Record Highs, New York Bodegas Get Creative And Sell Three Packs For $2.99

Politics

General

BNTX

MRNA

Robert F. Kennedy Jr. Sworn In as HHS Secretary

Rumors

INCY

Watching Incyte Shares, Hearing M&A Blog Mentions Merck As Potential Buyer

Shares of Reddit Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) tanked in early trading on Thursday, despite the company reporting <a href="https://www.benzinga.com/general/social-media/25/02/43676199/reddit-q4-earnings-revenue-beat-eps-beat-shares-slide-as-user-growth-slows">upbeat fourth-quarter results</a>.
Here are some key analyst takeaways.
<ul>
<li>Piper Sandler <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5981fdcbc1f558000155e858/thomas-champion">analyst Thomas Champion</a> maintained an Overweight rating, while raising the price target from $197 to $210.</li>
<li>JMP Securities <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/598858a9803ad30001474c48/andrew-boone">analyst Andrew Boone</a> reiterated a Market Outperform rating, while lifting the price target from $190 to $200.</li>
<li>Needham <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/580607ae846faa000106ab43/laura-martin">analyst Laura Martin</a> maintained a Buy rating, while raising the price target from $190 to $220.</li>
<li>Goldman Sachs <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587e33195064ed000173030b/eric-sheridan">analyst Eric Sheridan</a> reiterated a Neutral rating, while lifting the price target from $176 to $185.</li>
<li>JPMorgan <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/591479b8290fa7000138e4b4/doug-anmuth">analyst Doug Anmuth</a> reiterated a Neutral rating, while cutting the price target from $142 to $185.</li>
</ul>
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Piper Sandler: Reddit delivered "another quarter of strong results," with revenues of $428 million, up 71% year-on-year and 23% sequentially, Champion said. "User growth remains solid with Global DAUs (daily active users) climbing to around 102 million on average in the fourth quarter, he added.
"Management highlighted the improvements to ML models including translating content via machine translation," the analyst wrote. The number of languages will expand from the current eight in 2025 and "is driving 40-50% of international user growth," he further wrote.
JMP Securities: Reddit reported DAU and revenue 2% and 5% above consensus, respectively, while EBITDA came in $23 million higher, Boone said. "However, the revenue beat tightened (vs. 3Q24) and U.S. DAUq declined Q/Q," he added.
The sequential decline in US DAUs "highlights the volatility of SEO as Reddit's goal of reaching 1B DAU seems further away after the quarter," the analyst wrote. The company has "multiple growth levers" that can support meaningful free cash flow ahead, he further stated.
Needham: Reddit's fourth-quarter revenue growth accelerated to 71% year-on-year from 62% in 2024, Martin said. Total ad revenues in the quarter reached $395 million, up 60% year-on-year, she added.
The company reported DAUs of 101.7 million, up 39% year-on-year and 5% sequentially, including 46% growth in international DAUs, the analyst stated. "AI-driven language translations should accelerate int&#8217;l DAU growth in FY25," she further wrote.
Goldman Sachs: Reddit's fourth-quarter results, which came in "solidly above the guided range," reflects continued operating momentum, Sheridan said. US DAUs came in below Street estimates due to Google traffic changes but this was offset by strong international user growth, he added.
Management's commentary was positive around "both the scope/impact of AI across the platform as well as continued progress on monetization in the coming years," the analyst stated. "Our conviction level in Reddit's ability to sustainably grow revenues well above industry average rates increased with this set of results," he further wrote.
JPMorgan: While DAU growth softened after Thanksgiving, this was due to a change in the Google search algorithm, Anmuth said. "The search traffic headwinds did not impact either logged in user growth or the fourth-quarter revenue, and the company indicated that search traffic has recovered so far in the first quarter, he added.
"Despite DAUq headwinds, Reddit continues to execute well &amp; capture share of advertiser budgets," the analyst wrote. Strong revenue growth and improved cost leverage supported strong profit gains, with Reddit growing revenue around 4.2 times faster than non-GAAP expenses in 2024, he further stated.
Price Action: Shares of Reddit had declined by 5.53% to $204.50 at the time of publication on Thursday.
Read More:<a href="https://www.benzinga.com/25/02/43485175/amd-alphabet-snap-chipotle-and-tesla-why-these-5-stocks-are-on-investors-radars-today"></a> 
<ul>
<li><a href="https://www.benzinga.com/25/02/43697537/robinhood-gilead-sciences-crocs-lincoln-electric-hubspot-ge-healthcare-and-other-big-stocks-moving-higher-on-thursday">Reddit CEO Acknowledges Google Search Update&#8217;s Impact On Traffic But Shrugs It Off: &#8216;These Changes Happen All The Time&#8217;</a></li>
</ul>
Image: Shutterstock

Analyst Color

Earnings Beats

Social Media

Price Target

Reiteration

Movers

Trading Ideas

RDDT

Reddit Posts Solid Q4, Analysts Expect AI Language Translations To Grow Daily Active Users

Upwork Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>) shares are <a target="_blank" href="http://benzinga.com/news/earnings/25/02/43678290/upwork-shares-rise-on-strong-q4-earnings-we-are-poised-to-continue-to-gain-market-share" rel="noreferrer noopener">trading higher on Thursday.</a>
The company&#8217;s total revenue increased 4% year-over-year. Active clients totaled 832,000 at quarter&#8217;s end. Gross services volume per active client came in at $4,815, up 1% year-over-year.
Upwork expects first-quarter revenue to be in the range of $186 million to $191 million. The company anticipates first-quarter adjusted earnings of 24 cents to 26 cents per share.
Here are the analysts&#8217;<a target="_blank" href="https://www.benzinga.com/quote/UPWK/analyst-ratings" rel="noreferrer noopener"> takes on the stock:</a>
<ul>
<li>RBC Capital Markets analyst Brad Erickson reiterated the Sector Perform rating on Upwork, raising the price forecast to $18 from $16.</li>
<li>Needham analyst Bernie Mcternan maintained the Buy rating on the stock, raising the price forecast to $19 from $17.</li>
<li>Piper Sandler analyst Matt Farrell reiterated the Overweight rating on the company, with a price forecast of $18.</li>
</ul>
See Also:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/25/02/43676276/robinhood-q4-earnings-highlights-record-revenue-eps-beat-analyst-estimates-crypto-revenue-up-700" rel="noreferrer noopener">Robinhood Q4 Earnings Highlights: Record Revenue, EPS Beat Analyst Estimates, Crypto Revenue Up 700%+</a>
RBC Capital Markets: The analyst notes that while Enterprise revenue is showing positive growth with improvements in key metrics, including a 13% year-over-year increase in take rates, there is also a positive impact from AI.
However, the analyst writes that GSV is still declining, and a recovery might depend on macroeconomic factors, as other initiatives may not have an effect until 2026.
Erickson raises estimates, but remains cautious about giving a more positive rating until clearer signals of long-term growth are seen. The analyst raised the FY25 adjusted EBITDA estimate to $187.5 million from $176.5 million.
Needham: The analyst sees a slow macro environment in 2025, with lower take rate benefits and a decline in GSV and revenue year-over-year. The company plans to focus on AI, Enterprise, and Ads &amp; monetization in this investment year, aiming for growth in 2026 and beyond.
Despite these challenges, the analyst models an 8% growth in adjusted EBITDA, driven by 250 basis points of margin expansion, which remains a strong element of the Upwork story while waiting for macro conditions to improve.
The analyst is raising FY25 revenue and adjusted EBITDA estimates by 3% and 9%, respectively, due to higher take rate assumptions, though slightly offset by lower GSV expectations.
This adjustment follows the company&#8217;s better-than-expected performance in the fourth quarter, with revenue exceeding expectations by 6% and adjusted EBITDA by 25%.
Piper Sandler: The analyst notes that Upwork is concentrating on controllable factors, investing in AI, enterprise, and ads/monetization for growth.
Farrell remains impressed with the company&#8217;s ability to expand EBITDA margins, aiming for 35% over the next five years. Overall, per the analyst, estimates are likely to rise, assuming no significant changes in the macro environment.
Price Action: UPWK shares are trading higher by 7.08% to $16.63 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43694603/hertz-misses-on-revenue-profit-as-fleet-shrinks-costs-weigh" target="_blank" rel="noreferrer noopener">Hertz Misses On Revenue, Profit As Fleet Shrinks, Costs Weigh</a></li>
</ul>
Photo via Shutterstock.

Equities

UPWK

Upwork Gains On AI And Enterprise Growth, But Analysts See Macro Challenges Limiting Upside

On Wednesday,&nbsp;CVS Health Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) reported fourth-quarter sales of $97.71 billion, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $97.19 billion</a>.
Total revenues increased 4.2%, driven by growth in the Health Care Benefits and Pharmacy &amp; Consumer Wellness segments, partially offset by a decline in the&nbsp;<a target="_blank" href="https://www.benzinga.com/25/02/43655820/cvs-health-stock-surges-on-better-than-expected-q4-earnings-upbeat-annual-outlook" rel="noreferrer noopener">Health Services segment</a>.
The Medical benefit ratio increased from 88.5% to 94.8% compared to the prior year, driven by increased utilization, the unfavorable impact of the previously disclosed decline in the company&#8217;s Medicare Advantage star ratings for the 2024 payment year, and the impact of higher acuity in Medicaid.
Truist analyst noted that CVS Health&#8217;s fourth-quarter results were mostly better than expected, and the company provided strong guidance for 2025.
In its business segments, revenue projections for Health Services and Pharmacy &amp; Consumer exceeded expectations. However, the Health Care Benefits (HCB) segment fell short due to lower-than-expected membership growth.
Meanwhile, the medical benefit ratio (MBR) is expected to improve by 1 percentage point year-over-year, reaching at least 91.5%, which aligns with prior estimates and is slightly better than the 92.0% consensus.
Analyst David MacDonald writes CVS expects its Medicare Advantage (MA) margins to improve in 2025 from the negative 4.5% to 5.0% range seen in 2024, though they won&#8217;t break even yet. Management reaffirmed their long-term goal of a 3% to 5% margin.
For the overall business, CVS projects Health Care Benefits (HCB) margins to reach 1.5% in 2025, significantly lower than 5%+ in 2023 and 7% in 2022.
Management noted that each percentage point of HCB margin improvement adds about $0.75 to adjusted EPS, implying a $3 to $4 earnings boost if margins return to target levels over time.
<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41279374/cvs-health-positioned-for-medicare-margin-expansion-and-market-share-gains-says-bar" rel="noreferrer noopener">CostVantage is gaining traction</a>, with all commercial contracts using the model as of January 1, Truist writes. The company is also developing a cost-based approach for Medicare and Medicaid.
For 2025, revenue is projected to reach at least $134 billion, surpassing the previous estimate of $128 billion, driven by slightly higher prescription volumes (1.77 billion vs. 1.74 billion previously expected). The company sees 2025 as a transition year for CostVantage, with stronger growth potential in the future.
Finally, while leverage remains above the company&#8217;s long-term target, Truist expects better operational performance, especially at Aetna, to drive improvement over time.
The analyst maintains the Buy rating with an increased price forecast of <a target="_blank" href="https://www.benzinga.com/quote/CVS/analyst-ratings" rel="noreferrer noopener">$76, up from $60</a>.
Other analyst reactions:
<ul>
<li>Leerink Partners upgrades CVS Health to Outperform rating, raising the price forecast to $75.</li>
<li>Barclays analyst Andrew Mok maintains CVS Health with an Overweight rating, raising the price forecast from $71 to $73.</li>
<li>Wells Fargo analyst Stephen Baxter maintains the Overweight rating on CVS Health while raising the price forecast from $68 to $73.</li>
</ul>
Price Action: CVS stock is up 5.77% at $66.97 at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43692752/brewing-company-molson-coors-q4-gets-boost-from-higher-pricing-stock-rises" target="_blank" rel="noreferrer noopener">Brewing Company Molson Coors Q4 Gets Boost From Higher Pricing, Stock Rises</a></li>
</ul>
Photo by Around the World Photos via Shutterstock

Earnings

Large Cap

Upgrades

Health Care

CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock

Macro Economic Events

Commodities

Economics

Trump Will Meet With US Steel; Says Steel Tariffs Have Given US Steel More Power

Looking into the current session, WillScot Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WSC#NASDAQ">WSC</a>) shares are trading at $37.78, after a 2.52% increase. Moreover, over the past month, the stock increased by 3.31%, but in the past year, decreased by 24.65%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1739475911_0.png" alt="Past Year Chart" />

<h3>How Does WillScot Holdings P/E Compare to Other Companies?</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 35.91 in the Construction &amp; Engineering industry, WillScot Holdings Inc. has a higher P/E ratio of 307.08. Shareholders might be inclined to think that WillScot Holdings Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1739475911_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

P/E Ratio Insights for WillScot Holdings

WIIM

Bloom Energy shares are trading higher after the company announced a carbon capture partnership with Chart Industries.

Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>) has jumped 12% in seven days, fueled by Grayscale's application for the <a href="https://www.benzinga.com/25/02/43613700/cardano-outgains-bitcoin-ethereum-with-11-rally-after-its-first-ever-spot-etf-application-in-the-us">first spot ETF</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Cardano (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ada/usd">ADA</a>)</td>
<td>&nbsp;$0.8003</td>
<td>$28.2 billion</td>
<td>+2.5%&nbsp;</td>
<td>+12.6%&nbsp;</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$2,636.30</td>
<td>$317.7 billion</td>
<td>-1.5%</td>
<td>-2.2%&nbsp;</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.2566&nbsp;</td>
<td>$37.9 billion</td>
<td>-1.2%&nbsp;</td>
<td>+4%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: More Crypto Online foresees a bullish outlook as long as ADA stays above $0.684, with $0.65–$0.56 as the key lower support zone if broken.
A move above the February high would signal a push toward the $0.87–$0.94 Fibonacci extension.
While recent gains may be fuelled by ETF optimism, price action remains within corrective structures, warranting caution until key levels confirm a trend.
Crypto chart analyst Ali Martinez believes Cardano is likely repeating the same pattern from 2020 to 2021 at a slower pace. He predicts this could lead to a parabolic rally.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Looking back at history, <a href="https://twitter.com/hashtag/Cardano?src=hash&amp;ref_src=twsrc%5Etfw">#Cardano</a> <a href="https://twitter.com/search?q=%24ADA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ADA</a> seems to be repeating the same pattern from 2020 to 2021 at a slower pace, which could soon lead to a parabolic rally! Go to <a href="https://twitter.com/SimpleFXcom?ref_src=twsrc%5Etfw">@SimpleFXcom</a> via my link <a href="https://t.co/GLjkpQvNJr">https://t.co/GLjkpQvNJr</a>, claim the $5,000 bonus, and get some before it&#39;s too late! <a href="https://t.co/5aJn6aQjKC">pic.twitter.com/5aJn6aQjKC</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1889784292299219321?ref_src=twsrc%5Etfw">February 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Statistics: In a post on x on Wednesday, Santiment data shows Cardano's market cap having risen 11% despite a broader crypto retrace. 
Whales and sharks holding at least 1 million ADA have been accumulating since November 2023, adding 1.41 billion coins (2.35% of supply) over 15 months. 
Amid volatility, ADA&#8217;s <a href="https://x.com/santimentfeed/status/1889431054236172506">price</a> has surged 107% during this accumulation cycle. 
Martinez <a href="https://x.com/ali_charts/status/1890019592590012762">noted</a> that whales moved more than 70 million ADA in the past 96 hours.
Cardano has also dominated crypto discussions, with Ethereum and Dogecoin nearly absent from social chatter. 
Meanwhile, Bitcoin <a href="https://x.com/santimentfeed/status/1889448216875217103">remains</a> the most talked-about asset.
IntoTheBlock data shows Cardano's large transaction volume dropped 8.2% while daily active addresses increased 0.2%.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/02/43613700/cardano-outgains-bitcoin-ethereum-with-11-rally-after-its-first-ever-spot-etf-application-in-the-us">Cardano Outperforms Bitcoin, Ethereum With 11% Gains After Grayscale Applies For First Ever ADA Spot ETF In US</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ADA

$DOGE

$ETH

Cardano Jumps 12% In 7 Days: Why Is ADA Going Up?

Robinhood Markets Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) analysts on Thursday raised price targets on Robinhood shares following the company&#8217;s fourth-quarter results. Analysts are overwhelmingly impressed with profitability metrics combined with <a href="https://www.benzinga.com/news/earnings/25/02/43676276/robinhood-q4-earnings-highlights-record-revenue-eps-beat-analyst-estimates-crypto-revenue-up-700">accelerating growth</a>. 
Q4 Results: Robinhood reported a strong fourth quarter, with revenue of $1.01 billion coming in ahead of&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $944.62 million, and earnings of $1.01 per share beating estimates of 42 cents per share, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Total revenue was up 115% year-over-year, driven by strong transaction-based revenue growth across equities, options and cryptocurrency. Robinhood said net deposits hit a record of $16.1 billion in the quarter as accounts grew 10%. 
KeyBanc Maintains Overweight: Keybanc analyst Steve Barger maintained an <a href="https://www.benzinga.com/analyst-stock-ratings">Overweight rating</a> and raised the price target from&nbsp;$57&nbsp;to&nbsp;$75, citing improving profitability and momentum with key product initiatives.
The Keybanc analyst believes Robinhood is poised to continue its leadership in the financial application space and grow average revenue per user on the back of strong engagement, rapid uptake of new products, continued innovation and a maturing culture focused on responsible, profitable growth. 
&#8220;As a well-known and culturally relevant brand, Robinhood is well positioned to make further in-roads within the targeted segment across various financial products,&#8221; Barger said.
JMP Securities Maintains Market Outperform: JMP Securities analyst Devin Ryan maintained a Market Outperform and raised the price target from&nbsp;$60&nbsp;to&nbsp;$77, calling it a &#8220;blowout quarter&#8221; for Robinhood. 
&#8220;Robinhood is currently operating with tremendous momentum, and we see elevated growth persisting across virtually all aspects of its business, not to mention it is entering a number of new markets over the next year that are promising, and we envision incremental areas for innovation still to come beyond those,&#8221; the JPM Securities analyst said.
While Robinhood is seeing an acceleration in revenue, the company also remains focused on profitability, which Ryan expects to help support further margin expansion. The analyst noted that there are several growth drivers on the product roadmap that are not yet being accounted for in Street estimates.
Needham Maintains Buy: Needham analyst John Todaro maintained a Buy rating and raised the price target from&nbsp;$52&nbsp;to&nbsp;$70 after the company posted a &#8220;strong beat and solid outlook.&#8221;
Todaro echoed the sentiment of JMP&#8217;s Ryan, noting that Robinhood was able to maintain expense discipline and reach 60% EBITDA margins while reporting strong growth across all three transaction segments. 
&#8220;Robinhood is positioned to be a major beneficiary of more positive regulation within the crypto space, while emerging as a leader in its equity &amp; options offering via advanced trading product launches,&#8221; Todaro said.
&#8220;We expect HOOD to launch a number of new crypto related products, in particular those that appeal to a retail customer base, in 2025, which should allow the company to take share from centralized and decentralized peers.&#8221;
Check This Out: <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43697803/robinhoods-crypto-bet-pays-off-bernstein-predicts-massive-growth-105-price-target">Robinhood&#8217;s Crypto Bet Pays Off: Bernstein Predicts Massive Growth, $105 Price Target</a>
Goldman Sachs Maintains Buy: Goldman Sachs analyst James Yaro maintained a Buy rating and raised the price target from $54 to $62, calling it a &#8220;well-rounded quarter&#8221; for Robinhood.
Goldman appears to be less optimistic than the aforementioned analysts, albeit not by much. The analyst expects Robinhood to continue rolling out new products that will help the company capture market share and expand globally. 
Given the stronger trends in the fourth quarter, Yaro raised the net revenue estimates for full-year 2025 by 11%. The analyst also bumped full-year adjusted earnings estimates by 15%.
JPMorgan Maintains Neutral: JPMorgan analyst Kenneth Worthington is the least bullish of the bunch. The analyst maintained a Neutral rating and raised the price target from&nbsp;$39&nbsp;to&nbsp;$45, suggesting downside from current levels.
&#8220;Robinhood's platform is clearly maturing and evidencing its profitability, but we remain cautious on unproven business lines and valuation,&#8221; Worthington said. 
Robinhood shares are up 67% year-to-date and the stock has climbed more than 360% over the past year. The JPMorgan analyst acknowledged the significant progress at Robinhood, but remains cautious on new products and the scale of the company versus larger competitors. Worthington is also skeptical on the profitability potential of Robinhood&#8217;s smaller accounts.
&#8220;While we acknowledge the significant growth Robinhood has delivered the past 3-4yr, we remain Neutral given the competitive environment and varied outlook,&#8221; Worthington said. 
JPMorgan&#8217;s $45 price target for December is based on a 32-times earnings multiple and $2 billion in excess cash. 
HOOD Price Action: <a href="http://benzinga.com/quote/hood" target="_blank" rel="noreferrer noopener">Robinhood shares</a> were up 13% at $63.14 at the time of writing Thursday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/02/43683255/robinhood-ceo-vlad-tenev-says-prediction-markets-are-the-future-amid-super-bowl-lix-suspension-and-missing-regulatory-clarity">Robinhood CEO Vlad Tenev Says &#8216;Prediction Markets Are The Future&#8217; Amid Super Bowl LIX Suspension And Missing &#8216;Regulatory Clarity&#8217;</a></li>
</ul>
Photo: Shutterstock.

Long Ideas

HOOD

5 Robinhood Analysts React To 'Blowout' Q4 Earnings: Can The 'Tremendous Momentum' Continue?

2024's ETF Relay: Yield, Protection, Crypto Share The Podium

In this video, I discuss ETF strategies for navigating changes to interest rates. I also cover strategies for dividends, equity growth, and income.

Comments

ALPS ETF Trust ALPS

Vendite allo scoperto

ALPS ETF Trust ALPS (ARCA:SMTH), Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO